Evidence map›Paper›PMID 36320733›Full record

ReviewRSC advances2022

Antimicrobial activities and mechanisms of extract and components of herbs in East Asia.

Jingru Liang, Xuan Huang, Guo Ma

Abstract readReview
In one paragraph

Review in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Evaluation of the Antibacterial Activity ofCurrent pharmaceutical design · 2026
    Article
  6. Antimicrobial effects of compound Huangbai liquid onAmerican journal of translational research · 2026
    Article
  7. Article
  8. Article
  9. Nutraceutical Potential ofMetabolites · 2025
    Article
  10. Article
  11. Kinetic Study ofPolymers · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The Inhibitory Effect ofMolecules (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jingru LiangDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University 826 Zhangheng Road Shanghai 201203 China mg0328@fudan.edu.cn +86-21-5198-0025.ORCID https://orcid.org/0000-0002-1831-8741
Xuan HuangDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University 826 Zhangheng Road Shanghai 201203 China mg0328@fudan.edu.cn +86-21-5198-0025.
Guo MaDepartment of Clinical Pharmacy, School of Pharmacy, Fudan University 826 Zhangheng Road Shanghai 201203 China mg0328@fudan.edu.cn +86-21-5198-0025.ORCID https://orcid.org/0000-0001-5524-7172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial drugs face increasing challenges due to drug resistance and adverse reactions, which has created a pressing need for the discovery and development of novel antibacterial drugs. Herbs have played an important role in the treatment of infectious diseases. This review aims to summarize, analyze and evaluate the antibacterial activities and mechanisms of components from popular herbs in East Asia. In this review, we have searched and summarized the scientific papers published during the past twenty-year period from electronic databases such as PubMed, ScienceDirect, and Web of Science. These herbs and their components, including alkaloids, flavonoids, essential oils, terpenes, organic acids, coumarins and lignans, display potential antimicrobial effects. Herbal medicine formulas (HMFs) usually show stronger antibacterial activity than single herbs. Herbs and HMFs bring forth antibacterial activities by damaging cell membranes and walls, inhibiting nucleic acid and protein synthesis, and increasing intracellular osmotic pressure. These herbs and their components can be developed as potential and promising novel antibacterial herbal products.

Identifiers

PMID36320733
PMCPMC9554739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.